Phosphoinositide 3-Kinase Gamma (PI3K&ggr;) Inhibitors for the Treatment of Inflammation and Autoimmune Disease

Publisher： Bentham Science Publishers

E-ISSN： 2212-2710|4|1|1-15

ISSN： 1872-213X

Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.4, Iss.1, 2010-01, pp. : 1-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Isoform Selective Phosphoinositide 3-Kinase amp;#947; and amp;#948; Inhibitors and Their Therapeutic Potential

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 2, Iss. 1, 2008-01 ,pp. : 1-10

Bentham Science Publishers

Access to resources Recommend Favorite

JAK3 Inhibitors in Organ Transplantation and Autoimmune Disease

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 4, Iss. 1, 2010-01 ,pp. : 75-81

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Phosphoinositol 3 Kinase and NF&kgr;B for the Treatment of Chronic Obstructive Pulmonary Disease

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 5, Iss. 3, 2011-09 ,pp. : 178-183

Bentham Science Publishers

Access to resources Recommend Favorite

PI3K-Akt Signaling and Viral Infection

By  

Recent Patents on Biotechnology, Vol. 2, Iss. 3, 2008-11 ,pp. : 218-226

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Role of Rho-Associated Protein Kinase Inhibitors for Glaucoma Treatment

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 2, 2012-05 ,pp. : 89-98

Bentham Science Publishers

Access to resources Recommend Favorite